Priority Date: 03.08.12 (US 201261679461P)

CELL-SPECIFIC DELIVERY OF MIRNA MODULATORS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS

  • Application ID: EP13747630
  • Status: EXAMINATION IN PROGRESS

Attorney

Company dna icosa
no operation time available
625.38
1 office
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Icosa is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 172 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 03.08.2012 - Priority Date (US 201261679461P)
  • 06.02.2014 - Publication A1 (WO2014022852)
  • 10.06.2015 - Publication A1 (EP2880161)